Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Ethnopharmacol ; 286: 114921, 2022 Mar 25.
Artículo en Inglés | MEDLINE | ID: mdl-34921962

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Zanthoxylum piperitum has been used as a traditional Asian medicine to treat hypertension, stroke, bruise and muscle pain. It has been known to induce detoxification; affect anti-bacterial, anti-oxidant, and tyrosinase activity; inhibit osteosarcoma proliferation; anti-osteoarthritis inflammation. In this study, we aim to identify the therapeutic effect of Z. piperitum 90% EtOH extract (ZPE-LR) on rheumatoid arthritis. MATERIAL AND METHODS: We investigated the anti-rheumatoid arthritis and -immunomodulatory activities of the ZPE-LR in collagen-induced arthritic (CIA) mice, a rheumatoid arthritis animal model. In order to assess the analgesic effects of ZPE-LR in vivo, acetic acid injection, formaldehyde injection, hot plate model was used. The mechanism for anti-inflammatory activity of ZPE-LR was identified with LPS-stimulated Raw 264.7 cells. RESULTS: Pharmacologically, oral administration of ZPE-LR into CIA mice resulted in a significant and dose-dependent decrease in clinical arthritis score and paw swelling compared to untreated negative control. Pathologic examination showed that ZPE-LR prevented morphological change in cartilage and destruction of phalanges in CIA mice. This protective effect was associated with reduced pain, inflammatory mediators such as NO, TNF-α, IL-1ß, and IL-6, as well as COX-2 and iNOS expression. Furthermore, reduction of phosphor-ERK and BDNF indicates a novel rheumatoid arthritis-regulating mechanism by ZPE-LR treatment. CONCLUSIONS: These data suggest that the administration of ZPE-LR remarkably inhibited CIA progression and might be helpful in suppressing inflammation and pain in rheumatoid arthritis.


Asunto(s)
Artritis Experimental/tratamiento farmacológico , Artritis Reumatoide/tratamiento farmacológico , Inflamación/tratamiento farmacológico , Extractos Vegetales/farmacología , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/aislamiento & purificación , Antiinflamatorios/farmacología , Artritis Experimental/patología , Artritis Reumatoide/patología , Colágeno Tipo II , Relación Dosis-Respuesta a Droga , Inflamación/patología , Mediadores de Inflamación/aislamiento & purificación , Masculino , Ratones , Ratones Endogámicos DBA , Mialgia/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Células RAW 264.7 , Zanthoxylum
2.
J Microbiol Biotechnol ; 28(8): 1391-1400, 2018 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-30111075

RESUMEN

Angelica tenuissima root has historically been used as a traditional medicine in Korea. Previous studies have identified the anti-melanogenic effects of the extract of A. tenuissima root fermented by Aspergillus oryzae (FAT). This study investigated the protective effects of FAT against ultraviolet light B exposure (UVB; 30 mJ/cm2) in HaCaT (human keratinocyte) or Hs68 (human foreskin fibroblast) skin cells. FAT treatment was able to stimulate wound healing rate at the basal condition. FAT also favored the maintenance and/or improvement of extracellular matrix impairment caused by UVB irradiation through: 1) upregulation of procollagen Type-1 synthesis and secretion; 2) suppression of MMP-1 and elastase expression. FAT was able to play a role in the attenuation of inflammatory responses caused by UVB irradiation via upregulation of photo-protective hemeoxygease-1 and suppression of proinflammatory cyclooxygenase-2 expression. After further verification of the anti-photoaging potential of FAT, it could be utilized as an effective ingredient in anti-aging and anti-wrinkle cosmetics.


Asunto(s)
Angelica/química , Aspergillus oryzae/metabolismo , Alimentos Fermentados , Regulación de la Expresión Génica/efectos de los fármacos , Hemo-Oxigenasa 1/genética , Protectores contra Radiación/farmacología , Envejecimiento de la Piel/efectos de los fármacos , Línea Celular Transformada , Movimiento Celular/efectos de los fármacos , Ciclooxigenasa 2/genética , Regulación de la Expresión Génica/efectos de la radiación , Humanos , Queratinocitos/citología , Metaloproteinasa 1 de la Matriz/genética , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/genética , Estrés Oxidativo/efectos de la radiación , Elastasa Pancreática/genética , Elastasa Pancreática/metabolismo , Extractos Vegetales/química , Raíces de Plantas/química , Procolágeno/genética , Procolágeno/metabolismo , Rayos Ultravioleta/efectos adversos , Cicatrización de Heridas/efectos de los fármacos
3.
Int Immunopharmacol ; 11(12): 2062-72, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21939783

RESUMEN

The major compound of bee venom, melittin, has been used as an anti-inflammatory reagent for decades. However, the potential of melittin to ameliorate acute pancreatitis (AP) is unknown. Our aim was to investigate the effect of melittin on cerulein-induced AP. Pre- and post-treatment with melittin inhibited histological changes in the pancreas and lungs during cerulein-induced AP. Pancreatic weight/body weight ratios; digestive enzymes, including amylase and lipase; serum and pancreatic cytokine expression; and myeloperoxidase activity were decreased. In addition, treatment with melittin inhibited the activation of c-Jun NH(2)-terminal protein kinase (JNK) in the pancreas during cerulein-induced pancreatitis. In accordance with the results of in vivo experiments, melittin reduced cerulein-induced cell death, and production of inflammatory cytokines. In conclusion, our results suggest that melittin attenuated AP and AP-associated lung injury through the inhibition of JNK activation.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Ceruletida/antagonistas & inhibidores , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Meliteno/uso terapéutico , Pancreatitis Aguda Necrotizante/tratamiento farmacológico , Amilasas/sangre , Animales , Muerte Celular/efectos de los fármacos , Ceruletida/administración & dosificación , Citocinas/biosíntesis , Citocinas/sangre , Femenino , Lipasa/sangre , Pulmón/efectos de los fármacos , Pulmón/enzimología , Pulmón/fisiopatología , Ratones , Ratones Endogámicos C57BL , Pancreatitis Aguda Necrotizante/inducido químicamente , Pancreatitis Aguda Necrotizante/enzimología , Pancreatitis Aguda Necrotizante/patología , Peroxidasa/sangre , Resultado del Tratamiento
4.
J Nat Med ; 65(1): 63-72, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20799070

RESUMEN

Nardostachys jatamansi (NJ) has been used in the treatment of inflammatory diseases. However, it is not clear how NJ produces anti-inflammatory effects. In the present study, using an experimental model of lipopolysaccharide (LPS)-induced endotoxin shock, the protective effects and mechanisms of action of NJ were investigated. The water extract of roots of NJ was administrated to mice orally (1, 5, and 10 mg/kg) 1 h after or before LPS challenge. The administration of NJ inhibited LPS-induced endotoxin shock and the production of inflammatory mediators, such as interleukin (IL)-1ß, IL-6, tumor necrosis factor (TNF)-α, and interferon (IFN)-α/ß. Murine peritoneal macrophages were used to determine the production of inflammatory mediators. In peritoneal macrophages, NJ also inhibited LPS-induced production of inflammatory mediators, such as IL-1ß, IL-6, TNF-α, and IFN-α/ß. In addition, NJ reduced the activation of mitogen-activated protein kinases (MAPKs) and the level of expression of interferon regulatory factor (IRF)-1 and IRF-7 mRNA. Furthermore, post-treatment with NJ reduced LPS-induced endotoxin shock and the production of inflammatory mediators. These results suggest that NJ inhibits endotoxin shock by inhibiting the production of IL-1ß, IL-6, TNF-α, and IFN-α/ß through the inhibition of MAPKs activation and IRF induction.


Asunto(s)
Lipopolisacáridos/toxicidad , Nardostachys/química , Extractos Vegetales/química , Extractos Vegetales/uso terapéutico , Raíces de Plantas/química , Choque Séptico/tratamiento farmacológico , Animales , Western Blotting , Células Cultivadas , Ensayo de Inmunoadsorción Enzimática , Femenino , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Ratones , Ratones Endogámicos C57BL , Factor de Necrosis Tumoral alfa/metabolismo
5.
Int J Mol Med ; 27(1): 53-61, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21069254

RESUMEN

Curcuma longa (CL) has been reported to possess a variety of pharmacological activities. However, the effects of CL on acute pancreatitis (AP) have not yet been determined. To this end, we examined the effects of CL on cerulein-induced AP. Cell viability and cytokine productions were measured in pancreatic acini. Mice were divided into 3 groups: i) Normal group, ii) normal saline-treated group, iii) group treated with CL at a dose of 0.05, 0.1, 0.5 and 1 g/kg. CL was administered orally to mice for 7 days. The mice were intraperitoneally injected with the stable cholecystokinin analogue, cerulein (50 µg/kg), every hour for a total of 6 h. The mice were sacrificed 6 h after the completion of the cerulein injections. Blood samples were obtained to determine serum amylase, lipase and cytokine levels. The pancreas was rapidly removed for morphological examination, measurement of tissue myeloperoxidase activity, as well as the level of cytokines and heme oxygenase-1 (HO-1). The CL treatment reduced cerulein-induced cell death and cytokine production in pancreatic acini. The administration of CL significantly ameliorated the severity of pancreatitis and pancreatitis-associated lung injury, as was shown by the reduction in pancreatic edema, neutrophil infiltration, vacuolization, necrosis, serum amylase, lipase and cytokine levels, and mRNA expression of multiple inflammatory mediators such as interleukin (IL)-1ß and -6 and tumor necrosis factor (TNF)-α. In order to identify the regulatory mechanism of CL on cerulein-induced pancreatitis, we examined the level of HO-1 in the pancreas. We found that the administration of CL induced HO-1. Our results suggest that CL plays a protective role in the development of AP and pancreatitis-associated lung injury.


Asunto(s)
Ceruletida/farmacología , Curcuma/química , Lesión Pulmonar/tratamiento farmacológico , Pancreatitis/inducido químicamente , Pancreatitis/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Enfermedad Aguda , Animales , Citocinas/genética , Citocinas/metabolismo , Femenino , Hemo-Oxigenasa 1/metabolismo , Lesión Pulmonar/etiología , Lesión Pulmonar/patología , Ratones , Ratones Endogámicos C57BL , Páncreas/citología , Páncreas/efectos de los fármacos , Páncreas/metabolismo , Páncreas/patología , Pancreatitis/complicaciones , Peroxidasa/metabolismo
6.
Eur J Pharmacol ; 642(1-3): 154-62, 2010 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-20621590

RESUMEN

Piperine, a main component of Piper longum Linn. and Piper nigrum Linn., is a plant alkaloid with a long history of medical use. Piperine exhibits anti-inflammatory activity; however, the underlying mechanism remains unknown. We examined the effects of piperine on lipopolysaccharide (LPS)-induced inflammatory responses. Administration of piperine inhibited LPS-induced endotoxin shock, leukocyte accumulation and the production of tumor necrosis factor-alpha (TNF-alpha), but not of interleukin (IL)-1beta and IL-6. In peritoneal macrophages, piperine inhibited LPS/poly (I:C)/CpG-ODN-induced TNF-alpha production. Piperine also inhibited LPS-induced endotoxin shock in TNF-alpha knockout (KO) mice. To clarify the inhibitory mechanism of LPS-induced endotoxin shock, type 1 interferon (IFN) mRNA expression was determined. Piperine inhibited LPS-induced expression of type 1 IFN mRNA. Piperine inhibited the levels of interferon regulatory factor (IRF)-1 and IRF-7 mRNA, and the phosphorylation and nuclear translocation of IRF-3. Piperine also reduced activation of signal transducer and activator of transcription (STAT)-1. In addition, activation of STAT-1 was inhibited in IFN-alpha/beta-treated cells by piperine. These results suggest that piperine inhibits LPS-induced endotoxin shock through inhibition of type 1 IFN production.


Asunto(s)
Alcaloides/farmacología , Benzodioxoles/farmacología , Inflamación/tratamiento farmacológico , Lipopolisacáridos/farmacología , Piperidinas/farmacología , Alcamidas Poliinsaturadas/farmacología , Alcaloides/uso terapéutico , Animales , Benzodioxoles/uso terapéutico , Femenino , Técnicas de Inactivación de Genes , Inflamación/inmunología , Inflamación/metabolismo , Interferón Tipo I/biosíntesis , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/metabolismo , Ratones , Ratones Endogámicos C57BL , Piperidinas/uso terapéutico , Alcamidas Poliinsaturadas/uso terapéutico , Factor de Transcripción STAT1/metabolismo , Choque Séptico/tratamiento farmacológico , Factor de Necrosis Tumoral alfa/deficiencia , Factor de Necrosis Tumoral alfa/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...